Table 6 Frequency of adverse events, serious adverse events, and serious SSIs by preoperative diagnosis
Preoperative diagnosis | HA/CMC powder (n = 105) | No adhesion barrier (n = 104) |
|---|---|---|
Cancer, n (%) | ||
Adverse event | 35 (33.3) | 18 (17.3) |
Serious adverse event | 17 (16.2) | 6 (5.8) |
Serious SSI | 4 (3.8) | 5 (4.8) |
Diverticulosis, n (%) | ||
Adverse event | 11 (10.5) | 12 (11.5) |
Serious adverse event | 2 (1.9) | 2 (1.9) |
Serious SSI | 2 (1.9) | 2 (1.9) |
Crohn’s disease, n (%) | ||
Adverse event | 7 (6.7) | 2 (1.9) |
Serious adverse event | 4 (3.8) | 1 (1.0) |
Serious SSI | 4 (3.8) | 1 (1.0) |
Ulcerative colitis, n (%) | ||
Adverse event | 5 (4.8) | 4 (3.8) |
Serious adverse event | 3 (2.9) | 1 (1.0) |
Serious SSI | 2 (1.9) | 0 |
Polyp (no cancer), n (%) | ||
Adverse event | 4 (3.8) | 4 (3.8) |
Serious adverse event | 1 (1.0) | 1 (1.0) |
Serious SSI | 0 | 0 |
Endometriosis | ||
Adverse event | 1 (1.0) | 1 (1.0) |
Serious adverse event | 1 (1.0) | 0 |
Serious SSI | 1 (1.0) | 0 |
Polyposis | ||
Adverse event | 1 (1.0) | 0 |
Serious adverse event | 0 | 0 |
Serious SSI | 0 | 1 (1.0) |
Other | ||
Adverse event | 2 (1.9) | 0 |
Serious adverse event | 1 (1.0) | 0 |
Serious SSI | 0 | 0 |